Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2026 Earnings Call Transcript February 9, 2026
Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.1.
Clint Tomlinson: Good morning, everyone. And welcome to the Anavex Life Sciences Corp. fiscal 2026 first quarter conference call. My name is Clint Tomlinson. I will be your host for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer...
